课题基金 / 基金详情

PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance

PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance
癌症中的 PP2a 蛋白丝氨酸/苏氨酸磷酸酶突变:功能后果和临床相关性
批准号:
238781
负责人:
Aparicio Samuel J
金额:
$42.9万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2015-09-01

项目摘要

项目成果

Aparicio Samuel J的其他基金

相似基金

相关文献

中文摘要
翻译
DNA测序技术在过去几年里突飞猛进,我们现在可以对肿瘤细胞的基因组进行排序,以识别其中包含的基因突变。虽然这是一个相对较新的领域,但我们已经在制作迪斯科了
英文摘要
DNA sequencing technology has advanced in leaps and bounds during the last few years, and we can now sequence the genomes of tumour cells to identify the gene mutations contained within. Although this is a relatively new field, we are already making disco
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer
  • 批准号:
    477662
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.79万
  • 财政年份:
    2023
  • 负责人:
    Aparicio Samuel J
  • 依托单位:
Mechanisms and targeting of repair deficient cancers with G-quadruplex small molecule ligands
  • 批准号:
    478057
  • 项目类别:
    Operating Grants
  • 资助金额:
    $76.35万
  • 财政年份:
    2023
  • 负责人:
    Aparicio Samuel J
  • 依托单位:
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer.
  • 批准号:
    477245
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Aparicio Samuel J
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    459667
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2021
  • 负责人:
    Aparicio Samuel J
  • 依托单位:
海外基金